AddBIO CTO is moving on
AddBIO has reached an important milestone with the completion of the first ever machine to add bone-strengthening drugs to implants on an industrial scale. Dr. Trine Vikinge has been instrumental in the development together with an international team of renowned consultants. They have taken the Zolidd technology from the university laboratory through to being an industry compatible and regulatory feasible product.
Dr Vikinge has now decided to leave AddBIO to take on new challenges elsewhere and therefore people with different skills will now be engaged in the further development of AddBIO.